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Background
Multiple sclerosis (MS) is an autoimmune disease affecting
the central nervous system that generally develops in
young adults. T lymphocytes play a key role in the patho-
genesis of MS. The main types of lymphocytes are CD4
(Thelper) and CD8 (Tkiller) cells. CD4 cells can further be
divided into Th1 and Th2 cells. Th1 cells are responsible
for sustaining the autoimmune response. In contrast, Th2
cells reduce inflammatory reactions. Previous investiga-
tions suggested that the inhibition of the Kv1.3 and IKCa1
channels enable the specific modulation of different lym-
phocyte subsets. The ratio of the above channels is dissim-
ilar in different types of lymphocytes. The inhibition of
these channels leads to reduced activation of lymphocytes,
and, therefore, to a decrease of the autoimmune reaction.
In our investigations we aimed to observe the differences
in lymphocyte activation upon the inhibition of the above
channels in the Th1, Th2, CD4 and CD8 subsets in MS
compared to healthy individuals. Furthermore, we aimed
to assess whether inhibition of lymphocyte potassium
channels may be a possible target for the future therapy of
MS.
Methods
We used flow cytometry for our investigations. We ana-
lyzed samples of 10 healthy individuals and 10 newly
diagnosed MS patients not receiving immunomodulatory
therapy. First, we separated lymphocytes and stained the
Th1, Th2, CD4 and CD8 subsets with cell surface mar-
kers. Then, cells were loaded with calcium-sensitive
fluorescent dyes and were treated with the blockers of
the above-mentioned channels. We activated cells with
phytohemagglutinine immediately before the flow
cytometry recording. Finally, data were evaluated by a
software developed in our laboratory.
Results
In MS, the reactivity of lymphocytes is increased com-
pared to healthy controls. In MS there was no difference
revealed between the investigated subsets upon blocking
the IKCa1 channels. The inhibition of Kv1.3 channels in
MS decreased the activation of CD8 cells to a higher
extent than that of CD4 cells, but such a difference was
not detectable between Th1 and Th2 cells.
Conclusions
Our findings suggest that the activation of lymphocytes
can be decreased in MS by blocking the investigated
channels. Although limited selectivity can be reached in
MS. Accordingly, further investigation is needed to assess
how the inhibition of lymphocyte potassium channels
modulates the whole immune response in MS.
Author details
1First Department of Pediatrics Budapest, Hungary. 2Szent János Hospital
Budapest, Hungary.
Published: 30 January 2013
doi:10.1186/1753-6561-7-S1-O6
Cite this article as: Eniko et al.: Investigation of a novel therapeutic
approach in multiple sclerosis. BMC Proceedings 2013 7(Suppl 1):O6.
* Correspondence: biroeniko92@gmail.com
1First Department of Pediatrics Budapest, Hungary
Full list of author information is available at the end of the article
Eniko et al. BMC Proceedings 2013, 7(Suppl 1):O6
http://www.biomedcentral.com/1753-6561/7/S1/O6
© 2013 Eniko et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
